The Discounted Cash Flow (DCF) valuation of Genomic Vision SA (GV.PA) is (1.26) EUR. With the latest stock price at 0.00 EUR, the upside of Genomic Vision SA based on DCF is -70081.8%.
Based on the latest price of 0.00 EUR and our DCF valuation, Genomic Vision SA (GV.PA) is a sell. selling GV.PA stocks now will result in a potential gain of 70081.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.1% - 4.5% | 4.3% |
| Long-term Growth Rate | 3.0% - 3.8% | 3.4% |
| Fair Price | (4.24) - (0.75) | (1.26) |
| Upside | -235872.5% - -41761.4% | -70081.8% |